Submission Details
| 510(k) Number | K850727 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 22, 1985 |
| Decision Date | June 25, 1985 |
| Days to Decision | 123 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | — |
K850727 is an FDA 510(k) clearance for the BHCG-ROCHE EIA, a Visual, Pregnancy Hcg, Prescription Use (Class II — Special Controls, product code JHI), submitted by Hoffmann-La Roche, Inc. (Nutley, US). The FDA issued a Cleared decision on June 25, 1985, 123 days after receiving the submission on February 22, 1985. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1155.
| 510(k) Number | K850727 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 22, 1985 |
| Decision Date | June 25, 1985 |
| Days to Decision | 123 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | — |
| Product Code | JHI — Visual, Pregnancy Hcg, Prescription Use |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1155 |